or
forgot password

    • cancer clinical trials in bristol, TN

    • Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
    Blue Ridge Medical Specialists, PC
    Bristol, Tennessee 37620
    Esophageal Cancer, Gastric Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Blue Ridge Medical Specialists PC
    Bristol, Tennessee 37620
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Blue Ridge Medical Specialists PC
    Bristol, Tennessee 37620
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Compare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Chronic Myeloid Leukemia
    Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP)
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Adenomatous Polyposis Coli
    Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Kidney Neoplasms
    Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Advanced Breast Cancer, Breast Cancer
    PF-00299804 As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Carcinoma, Non-small Cell
    Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Blue Ridge Medical Specialists PC
    Bristol, Tennessee 37620
    Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    Study Evaluating Neratinib Plus Paclitaxel VS Trastuzumab Plus Paclitaxel In ErbB-2 Positive Advanced Breast Cancer
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Breast Cancer, Advanced Breast Cancer
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    Blue Ridge Medical Specialists PC
    Bristol, Tennessee 37620
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    A Trial Of CVX-060, An Anti-Angiogenic COVX-Body, In Combination With Sunitinib In Patients With Advanced Renal Cell Carcinoma
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Solid Tumor, Kidney Neoplasms, Advanced Renal Cell Carcinoma
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Blue Ridge Medical Specialists PC

    Trial Locations
    Blue Ridge Medical Specialists PC
    Wellmont Bristol Regional Medical Center
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
    Internal Medicine and Pediatric Associates of Bristol, PC
    Bristol, Tennessee 37620
    Overactive Bladder
    Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
    Wellmont-Bristol Regional Medical Center
    Bristol, Tennessee 37620
    Lymphoma, Neurotoxicity, Therapy-related Toxicity
    Safety and Efficacy Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids
    Site Reference ID/Investigator# 58626
    Bristol, Tennessee 37620
    Heavy Uterine Bleeding, Uterine Fibroids
    Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery
    Blue Ridge Medical Specialists PC

    Trial Locations
    Blue Ridge Medical Specialists PC
    Wellmont Bristol Regional Medical Center
    Clear Cell Renal Cell Carcinoma, Stage IV Renal Cell Cancer
    Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Non-Hodgkin Lymphoma, Hodgkin Disease, Thrombocytopenia
    PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909)
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Melanoma, Breast Neoplasms, Carcinoma, Renal Cell, Lymphoma, T-Cell, Carcinoma, Non-Small-Cell Lung
    A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast Cancer
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Breast Neoplasms
    Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Carcinoma, Renal Cell, Kidney Neoplasms
    Study in Women With Metastatic Breast Cancer Whose Cancer Has Gotten Worse After Anthracycline and Taxane Therapy
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Breast Neoplasms, Neoplasm Metastasis
    A Study To Assess The Safety And Efficacy Of SU11248 In Patients With Gastrointestinal Stromal Tumor(GIST)
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Gastrointestinal Stromal Tumor
    SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell Carcinoma
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Carcinoma, Renal Cell
    SU011248 In The Treatment Of Patients With Bevacizumab (Avastin)-Refractory Metastatic Renal Cell Carcinoma
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Carcinoma, Renal Cell
    A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
    Blue Ridge Medical Specialists
    Bristol, Tennessee 37620
    Lung Cancer, Non-small-cell Lung Carcinoma
    Anti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung Cancer
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Lung Neoplasms, Carcinoma, Non-small Cell Lung
    Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine.
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Colorectal Neoplasms
    Study Evaluating Biomarkers In Relapsed/Refractory Pediatric Solid Tumors
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Adenocarcinoma, Neoplasms
    A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Non-small Cell Lung Cancer
    Study Of SU011248 In Combination With Docetaxel (Taxotere) And Prednisone In Patients With Prostate Cancer
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Prostatic Neoplasms
    Postmenopausal Evaluation and Risk-reduction With Lasofoxifene (PEARL)
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Osteoporosis
    Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Carcinoma, Non-Small-Cell Lung
    Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Osteoporosis
    Open Label Study Of SU011248 In Combination With Trastuzumab For Patients With Metastatic Breast Cancer
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Breast Neoplasms
    Study Evaluating the Safety Of HKI-272 (Neratinib) In Subjects With Advanced Non-Small Cell Lung Cancer
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Carcinoma, Non-Small-Cell Lung, Lung Neoplasms
    A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer
    Site Reference ID/Investigator# 2414
    Bristol, Tennessee 37620
    Lung Cancer, NSCLC, Non-Small-Cell Lung Cancer
    Randomized Ph 2 Trial Of Paclitaxel/Carboplatin /Bevacizumab + PF-3512676 And P/C/B Alone In Advanced Nonsquamous NSCLC
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Carcinoma, Non-Small-Cell Lung
    Trial Of Erlotinib With Or Without PF-3512676 In Advanced Non Small Cell Lung Cancer
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Carcinoma, Non-Small-Cell Lung
    Study Of The Efficacy And Safety Of SU-014813 In Patients With Metastatic Breast Cancer
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Breast Neoplasms
    Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase
    Mountain Empire Neurological Associates, PC, 3183 West State Street, Suite 1201
    Bristol, Tennessee 37620
    Multiple Sclerosis
    Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
    Holston Medical Group
    Bristol, Tennessee 37620
    Atrial Fibrillation, Atrial Flutter
    Phase 1 Study Of Aurora Kinase Inhibitor PF-03814735 In Patients With Advanced Solid Tumors
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Solid Tumors
    Expanded Access Program for Maraviroc At Multiple Centers
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Advanced HIV Infection
    Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE)
    Highlands Allergy and Asthma Center, PC
    Bristol, Tennessee 37620
    Hereditary Angioedema
    Efficacy Study of DX-88 (Ecallantide) to Treat Acute Attacks of Hereditary Angioedema (HAE)
    Highlands Allergy and Asthma Center, PC
    Bristol, Tennessee 37620
    Hereditary Angioedema
    A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Carcinoma, Non-Small Cell Lung
    Study With AG-013736 Combined With Chemotherapy And Bevacizumab In Patients With Metastatic Colorectal Cancer
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Colorectal Neoplasms
    Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women
    Study Facility
    Bristol, Tennessee 37620
    Hypoactive Sexual Desire Disorder
    Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Carcinoma, Pancreatic Ductal